{"id":"463256021850-41","name":"PTC Therapeutics","registrationDate":"2016-05-25T16:52:21.124+02:00","category":2,"subCategory":3,"legal":"Corporation","web":"http://www.ptcbio.com/en/","country":"United states","headAddress":"PTC Therapeutics Inc","headCity":"South Plainfield","headPostCode":"","headPhone":"(1908)2 22 70 00","boss":"Stuart Peltz","bossTitle":"Mr","bossPosition":"Chief Executive Officer","membersCount":1,"membersFTE":"0.25","membership":"EuropaBio&#xd;\nEUCOPE","memberOrga":"","goal":"Our mission at PTC Therapeutics has always been to build an integrated biopharmaceutical company based on our expertise in RNA biology. &#xd;<br />&#xd;<br />We have focused on discovering and developing novel oral treatments for patients with serious and life-limiting disorders. By targeting the processes that modulate RNA biology and affect protein production, we bring an innovative approach to drug discovery. &#xd;<br />&#xd;<br />We are focused particularly on the development of treatments for rare and neglected disorders.","acronym":"","interests":"Public Health, Research and innovation","euInitiatives":"We follow EU initiatives, policies and legislation relating to the pharmaceutical industry and specifically treatments for rare diseases.","lastUp":"2018-05-21T20:08:46.427+02:00","customers":"","costAbsolu":"","costRange":"10000-24999","turnoverAbsolu":0,"turnoverRange":""}